Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
exactly!! Is call employees!! and their job is to make sure is always full.
Refill. This could be another reason why is full. You are always so negative about SPNG. why?? basher?? short??naked short??
Refill:
1. A product packaged to replace the used contents of a container.
2. A second or subsequent filling.
If SPNG beat the 40 millions...... and they do 50 millions:
revenues of 50 millions, net income around 9 millions and O/S of 220 millions shares
220 millions x 9 millions= eps 0.04 x 2= 0.08 x 220 million shares= 17,600,000 market cap
So after the 10K(May09) SPNG would qualify for AMEX by Standard 3.
http://www.venturelawcorp.com/listing_requirements_amex.html
Sounds like a PLAN!! Anybody???
Yes for the 10Q-feb09.
For FEB09 I believe they will do between 19 to 23 millions.
Exactly!! Metter always says " we are going to do 40 millions" But with Spongebob and the summer season for auto sponges they can do an extra 10millions plus and then Metter could say " We did over 50 millions so now we qualify for AMEX by the rules of Standard 3" mmmm!! Sounds like a good plan to me. Let see what happen.
If SPNG do over 50 millions:
If they do over 50 millions they will qualify for AMEX without the price per share rule: Standard 3
http://www.venturelawcorp.com/listing_requirements_amex.html
New product!!!
From yahoo:
New product!!-SPNG-Pet bowl cleaner!!!
Uncle Norman's™ Pet Bowl Cleaner!!!
http://spongetech.com/index.php?option=c...
GO SPNG LONGS
Sentiment : Strong Buy
thanks!!!!!!!
agree!!. Even with this manipulation(shake), the volume was less than 1 million shares for a total of 3.4 millions by EOD. We need to stick with facts. The insiders and funds ownership is above 45% and probably more since we are so close to the FDA approval. So there is only a couple of millions shares available for sale so cheap.
PRICE FIX AH: 0.89
http://data.cnbc.com/quotes/gtcb/gtcb
About Ownership:
http://data.cnbc.com/quotes/GTCB/tab/8
Exactly!. here is more data( facts) about what I said before about FDA guidelines: GTCB is part of the data:
A. Adequacy and Appropriateness of using the NADA Provisions to Regulate GE Animals
A number of comments, particularly from the regulated industry, expressed the view that the NADA provisions of the Act gave FDA appropriate tools to oversee GE animals. Other comments noted that the NADA provisions were not designed to cover GE animals, or rDNA constructs in GE animals. The definition of a drug, in section 201(g) of the Act, includes “articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals;” and “articles (other than food) intended to affect the structure or any function of the body of man or other animals.” Because this definition applies to the rDNA construct intended to alter the structure or function of an animal, and for the reasons explained in the guidance, the NADA provisions of the Act apply to GE animals. See Guidance at 4-5. We believe that these provisions are adequate to address the safety concerns associated with such animals. Our experience to date in reviewing pending, but not yet approved, applications is that the NADA requirements work very well as a means of regulating GE animals.
A number of comments questioned why FDA issued a guidance, noting that regulations rather than guidances are needed to set out regulatory requirements. We note that requirements that apply to new animal drugs are established by statute and implementing regulations. The guidance document explains how those existing provisions apply to GE animals. We do not believe it necessary to promulgate new regulations because the existing regulatory structure is adequate to review the safety and effectiveness of GE animal-related applications. In addition to describing and clarifying statutory and regulatory requirements, the guidance recommends the types of data and other information needed to fulfill the regulatory requirements. Issuance of a guidance document is an appropriate means to convey such recommendations. See 21 CFR 10.115 (guidance documents describe the agency's interpretation of or policy on a regulatory issue).
B. Transparency
A number of comments noted that the NADA process does not allow for much public input, and that often the public does not know a new animal drug is under review until FDA approves it. Commenters stated that such lack of transparency is particularly inappropriate for products of a new and controversial technology such as the genetic engineering of animals. Other comments stated that developers of GE animals have the same need and deserve the same right to protect their confidential commercial information as do developers of conventional human and new animal drugs.
We are taking steps to increase the transparency of the GE animal review process. For example, we intend to hold public advisory committee meetings prior to approving any GE animal. Although we may revisit that policy in the future as we gain more experience with reviews of GE animals, we will keep in mind the public's desire for information regarding GE animal reviews.
On January 9, 2008, CVM participated in a public meeting of the FDA Blood Products Advisory Committee on the Biologics License Application (BLA) for recombinant human antithrombin III produced in the milk of GE goats. At this meeting, with the sponsor's agreement, CVM provided a summary of its review of the NADA pertaining to the GE goats, as well as a summary of the environmental assessment (EA) submitted in support of the NADA. For GE animals intended for food or other non-biopharm use, we intend to hold advisory committee meetings dedicated to consideration of the GE animal NADAs and environmental reviews.
New animal drug approvals are published in the Federal Register, codified in the Code of Federal Regulations, and posted on FDA's website at http://www.fda.gov/cvm/greenbook.html. We will also post a detailed summary of the information on which the approval is based at http://www.fda.gov/cvm/FOI/efoi.html.
We also plan to post statements describing our intent to exercise enforcement discretion with respect to specific GE animal lineages on our website.
gtcb will gap big time with the approval. Just one simple question, WHY the FDA set new guidelines for this new technology???
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01944.html
Funds know this will be approve, they manipulate the price as far as they can before the announcement. After that the buying pressure will be huge, they won't be able to manipulate. Plus can you imagine the amount of coverage from the press after the approval?? "The first drug made using genetically engineered animals"....
http://www.reuters.com/article/marketsNews/idINN0931526820090110?rpc=44
I was referring to the SEC filing, I apologize. My point is about the huge accumulation from funds. Funds are buying everything, FDA already set the guidelines for this technology. The manipulation is so obvious.
gtcb is under severe accumulation from funds, the manipulation is evident. I believe we will see 1.00-1.03 by EOD.
New institutional for GTC Biotherapeutics : Over 5% ownership
SC 13G/A 1 gtcba1.htm SONORA INVESTMENT MANAGEMENT:
http://idea.sec.gov/Archives/edgar/data/904973/000108514609000734/gtcba1.htm
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 5,409,111
(b) Percent of class: 5.29%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote 5,409,111
agree. Viacom-SPNG- spongebob characters can do more than 100 millions. Plus add the value of their technology with other products and you have probably more than 300 millions in sales in the next two years easy.
exactly Carpe!. This technology is worth hundreds of millions! SPNG- delivery systems will be the substitute of plastic bottles for so many products!. In 2000 US plastic bottle industry was worth more than 8 billions dollars!! In 2009 some research companies put that value in more than 16 billions!! If SPNG capture 2% of the plastic bottles market we are talking about more than 300 MILLIONS DOLLARS!!!!
Here are some facts about why SPNG- DELIVERY SYSTEM TECHNOLOGY is worth hundreds of millions!. This technology is the SUBSTITUTE of plastic bottles for so many products. Please take a look at the value of this industry:
"In 2000 U.S. manufacturing establishments shipped $8.0 billion worth of plastic bottles."
http://www.answers.com/topic/plastics-bottles
http://www.ibisworld.com/industry/retail.aspx?indid=519&chid=1
http://packaging.2456.com/eng/marketnews/details.asp?e=1&inewsiid=5&inid=74813&ptid=546
EXACTLY!! what make SPNG so unique is the technology- delivery system technology. The application of this technology to many cleaning, chemical, pharmaceutical products is worth HUNDRED OF MILLIONS DOLLARS!! Why there is so many rumors about buyout and big investor????. BECAUSE SOMEBODY WANT THE TECHNOLOGY AND ARE WILLING TO PAY MILLIONS FOR IT!!!
Thanks Soapy for the update on the Ibox!
Exactly carpe!!. People need to remember that recently SPNG announce a 25 millions shares buyback from the tradable. So the more UBSS hold the price down the quicker SPNG will finish this buyback.
100% agree. This big player #2 is an investor (long term=more money). They see the value of their technology, SPNG- delivery system is so unique, applications of their technology in the medical field could be worth hundreds of millions!!. This technology can change in the future the way people wash their cars, wash their dogs, make kids bath time fun, be the substitute of plastic bottles( earth friendly) and make the application of different medications more easy and cost effective( like acne( facial diseases ), other skin diseases) and for the purpose of cleaning medical equipment, etc, etc.
thanks Puppy. SPNG is an investment. This technology is unique. This delivery system could be the substitute of so many products that right now are only available in plastic bottles. This company is really small but after the next 10Q, things would look really different. Another thing- VIACOM(SPONGEBOB, DORA, GO DIEGO) WOULD NEVER, EVER STICK THEIR BRAND WITH A SMALL COMPANY UNLESS THEY ARE 100% SURE BUT REALLY SURE THEY WILL RECEIVE MILLIONS AND MILLIONS DOLLARS FROM ROYALTIES ( Viacom is a multi billion dollar business). IF THEY SAID YES TO DO BUSINESS WITH SPONGETECH IS BECAUSE THEY SEE THE BRIGHT FUTURE OF SPONGETECH PRODUCTS.
http://finance.yahoo.com/news/SpongeTechR-Delivery-Systems-prnews-13402013.html
thanks, As far as I understand from my DD and talks with management, This big investor is one of the key elements that will make the NSS cover because after the investor become public( and don't know the name just to clarify) others will come and the buying pressure will be huge because a lot of investors after the VW-Porsche squeeze realize that you can make a lot but a lot of money from a short squeeze. IMO the NSS commit a huge mistake with this company.
thanks, Agreed. The element of surprise is the key to short squeeze. Same as VW- Porsche, The company is working behind curtains and is obvious that the increase in the amount of bashers and negativity prove that they are really worry(NSS-guys). We need to remember something, Mr. Metter is been in the stockmarket for more than a decade so he really know how this NSS work. This is small company with an amazing growth curve. And more important NO DEBT!!
hi! first time posting here. I post on yahoo from time to time under another alias. I am long on spng. I really believe that management did this just to mess with the NSS. If you gag-TA, increase the A/S and then decrease O/S, start the buyback and move the numbers, THE NSS DON'T HAVE A CLUE ABOUT THE REAL O/S SO THEY DONT KNOW HOW MUCH THEY NEED TO COVER AND WHEN. So they keep the price down and try to collect as much air shares as they can until SPNG show the real numbers. This is a long term investment and a really good one. The balance sheet on the 10Q is really strong.